Search results
Results from the WOW.Com Content Network
Superior vena cava syndrome (SVCS), is a group of symptoms caused by obstruction of the superior vena cava ("SVC"), a short, wide vessel carrying circulating blood into the heart. The majority of cases are caused by malignant tumors within the mediastinum , most commonly lung cancer and non-Hodgkin's lymphoma , directly compressing or invading ...
The superior vena cava (SVC) is the superior of the two venae cavae, the great venous trunks that return deoxygenated blood from the systemic circulation to the right atrium of the heart. It is a large-diameter (24 mm) short length vein that receives venous return from the upper half of the body, above the diaphragm .
Inferior vena cava syndrome (IVCS) is a very rare constellation of symptoms resulting from either obstruction or stenosis of the inferior vena cava. It can be caused by physical invasion or compression by a pathological process, or by thrombosis within the vein itself. It can also occur during pregnancy. Symptoms including high venous pressure ...
Sjogren's syndrome "is a disorder of your immune system identified by its two most common symptoms — dry eyes and a dry mouth," according to the Mayo Clinic, while the National Institutes of ...
RSV vaccine side effects in older adults . The CDC lists the following as possible side effects of the RSV vaccine: Pain, redness, and swelling where the shot is given. Fatigue. Fever. Headache ...
A few months after surgery, Minton returned and Siuba conducted another heart catheterization to determine how she was faring. “If you take a patient with pulmonary hypertension and liver ...
Superior vena cava syndrome is a rare complication of arm DVT. [11] DVT is thought to be able to cause a stroke in the presence of a heart defect. This is called a paradoxical embolism because the clot abnormally travels from the pulmonary circuit to the systemic circuit while inside the heart.
Treatments for primary pulmonary hypertension such as prostacyclins and endothelin receptor antagonists can be fatal in people with PVOD due to the development of severe pulmonary edema, and worsening symptoms after initiation of these medications may be a clue to the diagnosis of pulmonary veno-occlusive disease.